Song Y, Gao S, Jiang J, Zhang Y, Zhang J, Wang X
Int J Mol Sci. 2025; 26(4).
PMID: 40003950
PMC: 11854995.
DOI: 10.3390/ijms26041485.
Snow A, Wijesiriwardena T, Lane B, Farrell B, Dowdle P, Katan M
Sci Rep. 2025; 15(1):2958.
PMID: 39848978
PMC: 11758000.
DOI: 10.1038/s41598-025-86194-6.
Lin Q, Zhang J, Qi J, Tong J, Chen S, Zhang S
Adv Sci (Weinh). 2024; 12(7):e2408688.
PMID: 39731358
PMC: 11831436.
DOI: 10.1002/advs.202408688.
Peng M, Deng J, Li X
Mol Cancer. 2024; 23(1):256.
PMID: 39543657
PMC: 11566285.
DOI: 10.1186/s12943-024-02167-9.
Giacomini A, Taranto S, Gazzaroli G, Faletti J, Capoferri D, Marcheselli R
J Exp Clin Cancer Res. 2024; 43(1):294.
PMID: 39482742
PMC: 11529022.
DOI: 10.1186/s13046-024-03217-2.
Advances in the role of membrane-bound transcription factors in carcinogenesis and therapy.
Deng J, Zhou J, Jiang B
Discov Oncol. 2024; 15(1):559.
PMID: 39404930
PMC: 11480308.
DOI: 10.1007/s12672-024-01414-1.
Engineering growth factor ligands and receptors for therapeutic innovation.
An X, Paoloni J, Oh Y, Spangler J
Trends Cancer. 2024; 10(12):1131-1146.
PMID: 39389907
PMC: 11631651.
DOI: 10.1016/j.trecan.2024.09.006.
Development of a Modular miRNA-Responsive Biosensor for Organ-Specific Evaluation of Liver Injury.
Zhang X, Wang T, Fan X, Wang M, Duan Z, He F
Biosensors (Basel). 2024; 14(9).
PMID: 39329825
PMC: 11430419.
DOI: 10.3390/bios14090450.
Exploring endocrine FGFs - structures, functions and biomedical applications.
Phan P, Ternier G, Edirisinghe O, Kumar T
Int J Biochem Mol Biol. 2024; 15(4):68-99.
PMID: 39309613
PMC: 11411148.
DOI: 10.62347/PALK2137.
A Promising Paradigm Shift in Cancer Treatment with FGFR Inhibitors.
Mehra A, Sangwan R
Anticancer Agents Med Chem. 2024; 25(1):2-23.
PMID: 39192641
DOI: 10.2174/0118715206318833240819031953.
Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance.
Marin A, Morales F, Walbaum B
Front Oncol. 2024; 14:1406951.
PMID: 39040443
PMC: 11260626.
DOI: 10.3389/fonc.2024.1406951.
regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis by PI3K/AKT/Hippo and MEK/ERK signaling.
Chen M, Liang H, Wu M, Ge H, Ma Y, Shen Y
Int J Biol Sci. 2024; 20(9):3461-3479.
PMID: 38993574
PMC: 11234224.
DOI: 10.7150/ijbs.94863.
Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer.
Li Z, Zhao H, Hu H, Shang H, Ren Y, Qiu W
Chin J Cancer Res. 2024; 36(3):306-321.
PMID: 38988489
PMC: 11230884.
DOI: 10.21147/j.issn.1000-9604.2024.03.07.
Landscape of targeted therapies for advanced urothelial carcinoma.
Shang S, Zhang L, Liu K, Lv M, Zhang J, Ju D
Explor Target Antitumor Ther. 2024; 5(3):641-677.
PMID: 38966172
PMC: 11220318.
DOI: 10.37349/etat.2024.00240.
FGFR4-driven plasticity in breast cancer progression and resistance to therapy.
Braun M, Piasecka D, Sadej R, Romanska H
Br J Cancer. 2024; 131(1):11-22.
PMID: 38627607
PMC: 11231301.
DOI: 10.1038/s41416-024-02658-y.
Calcium and Neural Stem Cell Proliferation.
Diaz-Pina D, Rivera-Ramirez N, Garcia-Lopez G, Diaz N, Molina-Hernandez A
Int J Mol Sci. 2024; 25(7).
PMID: 38612887
PMC: 11012558.
DOI: 10.3390/ijms25074073.
Ligand bias underlies differential signaling of multiple FGFs via FGFR1.
Karl K, Del Piccolo N, Light T, Roy T, Dudeja P, Ursachi V
Elife. 2024; 12.
PMID: 38568193
PMC: 10990489.
DOI: 10.7554/eLife.88144.
Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway.
Jin X, Jin W, Li G, Zheng J, Xu X
PeerJ. 2024; 12:e17123.
PMID: 38560469
PMC: 10981413.
DOI: 10.7717/peerj.17123.
Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review.
Sahin A, Babayev H, Cirigliano L, Preto M, Falcone M, Altintas E
Int J Impot Res. 2024; 36(8):801-808.
PMID: 38454161
DOI: 10.1038/s41443-024-00845-2.
Computer-aided engineering of stabilized fibroblast growth factor 21.
de La Bourdonnaye G, Ghazalova T, Fojtik P, Kutalkova K, Bednar D, Damborsky J
Comput Struct Biotechnol J. 2024; 23:942-951.
PMID: 38379823
PMC: 10877085.
DOI: 10.1016/j.csbj.2024.02.001.